Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: Adv Ther (Weinh). 2019 Sep 18;2(12):1900129. doi: 10.1002/adtp.201900129

Figure 3. Construction and characterization of GDLVs, ε-PLL-GDLVs, and LbL-GDLVs.

Figure 3.

A. LbL-GDLVs/Dox were constructed using a layer-by-layer technique. Ginger-derived lipids loaded with the therapeutic drug, doxorubicin (Dox), were first modified with ε-poly-lysine (ε-PLL) and then surface-coated with fucoidan via electrostatic interaction. B-D. Left: Transmission electron microscopic (TEM) images. Scale bar = 200 nm. Middle: Size distribution of nanoparticles, as assessed using dynamic light scattering (DLS). Right: Zeta potential (surface charge) of nanoparticles, as assessed using DLS.